All News

Adding Keytruda to pre-surgical chemotherapy then giving it again after surgery improved event-free survival and pathologic complete response in patients with early-stage lung cancer.

Participants in the RESTORE study, results of which were presented this weekend at ASCO, saw “significant improvements” in depression and anxiety symptoms after using the Attune app.

Patients with unresectable hepatocellular carcinoma treated with the STRIDE regimen, consisting of Imjudo and Imfinzi, experienced manageable immune-related side effects with improvements in overall survival.

Findings from the monarchE trial presented at ASCO showed that for patients with hormone receptor–positive, HER2-negative, high-risk, early breast cancer, Verzenio provided “consistent treatment benefit.”

Treating patients with metastatic castration-resistant prostate cancer with radium-223 also allowed patients to receive subsequent therapies such as chemotherapy.

The CAR-T cell therapy, Tecartus, improved outcomes for patients with B-cell acute lymphoblastic leukemia, offering a promising standard of care for this patient population.

A progression-free survival benefit was observed in patients with advanced ovarian cancer including those with homologous recombination deficient-positive status who were treated with frontline chemo plus Avastin and Imfinzi followed by maintenance therapy with an Avastin regimen.

Three-fourths of patients with relapsed/refractory B-cell acute lymphoblastic leukemia experienced complete responses — which tended to be durable — when treated with the CAR-T cell therapy, Obe-cel.

Results of the Canadian Cancer Trials Group CX.5/SHAPE trial could lead to surgical de-escalation among patients with cervical cancer.

After my daughter was diagnosed with cancer, I began to share my experiences through writing, and through that I found camaraderie — and heartbreak.

From Edward James Olmos and Khloé Karsashian both discussing their cancer diagnoses to a survivor making a movie musical about her diagnosis and more, here’s what’s happening in the oncology space this week.

Adding Kisqali to endocrine therapy tended to improve the amount of time patients with HR-positive, HER2-negative early breast cancer lived before their disease became invasive.

Days before I went on vacation, I learned that my blood cancer might have progressed to a more aggressive disease.

Rectal cancer is an overwhelming diagnosis for patients to receive. Anica Bausch's, B.S.N., RN, OCN calm and compassionate demeanor helps patients manage their anxiety and fears surrounding treatment and prognosis.

Who would have thought that a small dinosaur toy helped give me the strength to fight metastatic breast cancer?

‘Forwards,’ the new album by Mike Peters and the Alarm, was written while he was hospitalized for treatment of chronic lymphocyte leukemia and pneumonia.

The Food and Drug Administration granted a priority review for fruquintinib for patients with pretreated metastatic colorectal cancer.

Before every cancer scan, I used to prepare myself for the worst.

Lynparza plus abiraterone was approved by the FDA for the treatment of patients with deleterious or suspected BRCA-mutated metastatic castration-resistant prostate cancer.

The agency accepted a New Drug Application for repotrectinib, a TKI for the treatment of patients with locally advanced or metastatic non-small cell lung cancer.

I lost my hair during cancer treatment, but now that it’s growing back, I no longer obviously look like a patient.

Some symptoms of myeloproliferative neoplasms are “pretty broad,” highlighting the importance of open communication with cancer teams to manage the symptoms and improve quality of life.

Jessica Smith, B.S.N., RN, OCN, has been an oncology nurse for 27 years and continues to provide personalized, compassionate care to her patients as a direct care oncology nurse.

Patients with cancer often experience loneliness, and the COVID-19 pandemic helped the general public better understand what that isolation felt like, an expert said.

As part of its Speaking Out video series, CURE spoke with Monica Fawzy Bryant, Esq., from Triage Cancer, about how to better manage medical bills following a cancer diagnosis.

As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about choosing and using health insurance before, during and after a cancer diagnosis.

As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about working during a cancer diagnosis and its treatments, and what rights individuals have when it comes to employment and insurance.

As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about policies around taking extended time off from work for patients with cancer and their caregivers.